Hepatopulmonary syndrome other diagnostic studies

Hepatopulmonary syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatopulmonary syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatopulmonary syndrome other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatopulmonary syndrome other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatopulmonary syndrome other diagnostic studies
CDC on Hepatopulmonary syndrome other diagnostic studies
Hepatopulmonary syndrome other diagnostic studies in the news
Blogs on Hepatopulmonary syndrome other diagnostic studies
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Hepatopulmonary syndrome other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]

Overview

There are no other diagnostic studies associated with hepatopulmonary syndrome.

OR

Pulmonary function tests may be helpful in the diagnosis of hepatopulmonary syndrome. Findings suggestive of hepatopulmonary syndrome include A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) suggesting a diffusion impairment as afrequent finding in hepatopulmonary syndrome (occurring in up to 80% of patients). Six minute walk test with and without an oxygen titration can also use as an objective assessment of exercise capacity.

Other diagnostic studies for hepatopulmonary syndrome include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

Pulmonary Function Tests

• Usually PFT in HPS patients usually reveal normal flows and lung volumes,

• Pulmonary function testing (PFT) may be helpful in the diagnosis of hepatopulmonary syndrome.
• Findings suggestive of hepatopulmonary syndrome include:

• Diffusion impairment is a frequent finding in HPS, occurring in up to 80% of patients.
• Nevertheless this finding is frequent in people with cirrhosis who do not have HPS as well, (50-70% of cirrhotic patients)
• A decrease in the single-breath diffusing capacity for carbon monoxide (DLCO) (not specific) is the most prevalent finding.
• A mean DLCO of 55% predicted in HPS patients compared to a mean of 72% predicted in people with cirrhosis who do not have HPS .
• Reduced lung volumes might barely observed in tense ascites or in the presence of pleural effusions due to oncotic disturbance or other reasons. (neither specific nor sensitive)

Six Minute Walk Test With and Without an Oxygen Titration

• Objective assessment of exercise capacity

• A decrease below 88% O2 saturation with exertion calls for an oxygen titration study to identify and match oxygen requirements.